A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Tarih
2019Üst veri
Tüm öğe kaydını gösterÖzet
Objective: The aim of the present study was to evaluate the efficacyand safety of eltrombopag, an oral thrombopoietin receptor agonist,in patients with chronic immune thrombocytopenia (ITP).Materials and Methods: A total of 285 chronic ITP patients (187wo Amaç: Bu çalışmanın amacı kronik immün trombositopeni
(ITP) hastalarında bir oral trombopoietin reseptör agonisti olan
eltrombopagın etkinlik ve güvenirliliğini değerlendirmektir.
Gereç ve Yöntemler: Elli beş merkezde izlem altındaki toplam 285
kronik
Bağlantı
https://app.trdizin.gov.tr/makale/TXpVek56Y3dNQT09/a-multi-center-study-on-the-efficacy-of-eltrombopag-in-management-of-refractory-chronic-immune-thrombocytopenia-a-real-life-experiencehttps://doi.org/10.4274/tjh.galenos.2019.2018.0307
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/590
Koleksiyonlar
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
